StocksFin Logo
Evotec SE country of incorporation
|
|
4,715 employees
NASDAQ | Healthcare | Drug Manufacturers—Specialty & Generic
The Ensign Group, Inc. country of incorporation
|
|
Mr. Barry Port
|
25,900 employees
NASDAQ | Healthcare | Medical Care Facilities
Q322 reported Sep 30, 2022 Reporting Period
$173.88M 8.9% vs. Q321 Revenues Q322
16.34% -39.5% vs. Q321 Gross Profit Margin
-27.19% ! -132.3% vs. Q321 Net Profit Margin
-79.81M ! -483.8% vs. Q321 Free Cash Flow Q322
$-0.14 ! -132.9% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
0.24%
Q322 reported Oct 26, 2022 Reporting Period
$770.01M 15.2% vs. Q321 Revenues Q322
16.81% -5.4% vs. Q321 Gross Profit Margin
7.3% 3.2% vs. Q321 Net Profit Margin
69.87M -27.3% vs. Q321 Free Cash Flow Q322
$1.02 17.2% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
0.24%
Loading...
Loading...
Ratios
As of
Dec 31, 2022
Dec 31, 2022
Quick Ratio
2.92
1.27
Current Ratio
3.18
1.34
Cash Ratio
1.23
0.54
Price to Book
2.25
4.04
Price to Sales
3.55
1.66
Price to Earnings
-15.19
22.4